DPZ-Hauptseite
Menü mobile menu

2018

  1. Maschkowitz G, Gärtner S, Hofmann-Winkler H, Fickenscher H, Winkler M (2018): Interaction of human cytomegalovirus tegument proteins ppUL35 and ppUL35A with Sorting Nexin 5 regulates glycoprotein B (gpUL55) localization. Journal of Virology. 92(9). pii: e00013-18. doi: 10.1128/JVI.00013-18.
     
  2. Hoffmann M, Hofmann-Winkler H, Pöhlmann S (2018): Activation of Viruses by Host Proteases  - Priming Time: How Cellular Proteases Arm Coronavirus Spike Proteins. Springer International Publishing. doi: 10.1007/978-3-319-75474-1.
     
  3. González Hernández M, Hoffmann M, Brinkmann C, Nehls J, Winkler M, Schindler M, Pöhlmann S (2018): A GXXXA motif in the transmembrane domain of the Ebola virus glycoprotein is required for tetherin antagonism. Journal of Virology. 92(13). pii: e00403-18. doi: 10.1128/JVI.00403-18.
     
  4. Hoffmann M, Pöhlmann S (2018): Cell Entry of Influenza A Viruses: Sweet Talk between HA and CaV1.2. Cell Host Microbe. 23(6):697-699. doi: 10.1016/j.chom.2018.05.019.
     
  5. Zmora P, Hoffmann M, Kollmus H, Moldenhauer AS, Danov O, Braun A, Winkler M, Schughart K, Pöhlmann S (2018): TMPRSS11A activates the influenza A virus hemagglutinin and the MERS coronavirus spike protein and is insensitive against blockade by HAI-1. Journal of Biological Chemistry. 293(36):13863-13873. doi: 10.1074/jbc.RA118.001273.
     
  6. Kleine-Weber H, Elzayat MT, Hoffmann M, Pöhlmann S (2018): Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein. Scientific Reports. 8(1):16597. doi: 10.1038/s41598-018-34859-w.
     
  7. Krüger N, Sauder C, Hüttl S, Papies J, Voigt K, Herrler G, Hardes K, Steinmetzer T, Örvell C, Drexler JF, Drosten C, Rubin S, Müller MA, Hoffmann M (2018): Entry, Replication, Immune Evasion, and Neurotoxicity of Synthetically Engineered Bat-Borne Mumps Virus. Cell Reports. 25(2):312-320.e7. doi: 10.1016/j.celrep.2018.09.018.

 

2017

  1. Wrensch F, Hoffmann M, Gärtner S, Nehlmeier I, Winkler M, Pöhlmann S (2017): Virion Background and Efficiency of Virion Incorporation Determine Susceptibility of Simian Immunodeficiency Virus Env-Driven Viral Entry to Inhibition by IFITM Proteins. Journal of Virology. 91(2). pii: e01488-16. doi: 10.1128/JVI.01488-16.
     
  2. Winkler M, Gärtner S, Wrensch F, Krawczak M, Sauermann U, Pöhlmann S (2017): Rhesus macaque IFITM3 gene polymorphisms and SIV infection. PLoS One. 12(3):e0172847. doi: 10.1371/journal.pone.0172847.
     
  3. Hoffmann M, Crone L, Dietzel E, Paijo J, González-Hernández M, Nehlmeier I, Kalinke U, Becker S, Pöhlmann S (2017): A polymorphism within the internal fusion loop of the Ebola virus glycoprotein modulates host cell entry. Journal of Virology. 91(9). pii: e00177-17. doi: 10.1128/JVI.00177-17.
     
  4. Pöhlmann S, Krüger A, Hafezi W, Schneider S, Gruber J, Winkler M, Kaul A (2017): Detection systems for antibody responses against herpes B virus. Primate Biology. doi:10.5194/pb-4-9-2017.
     
  5. Reinke LM, Spiegel M, Plegge T, Hartleib A, Nehlmeier I, Gierer S, Hoffmann M, Hofmann-Winkler H, Winkler M, Pöhlmann S (2017): Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2. PLoS One. 12(6):e0179177. doi: 10.1371/journal.pone.0179177.
     
  6. Zmora P, Molau-Blazejewska P, Bertram S, Walendy-Gnirß K, Nehlmeier I, Hartleib A, Moldenhauer AS, Konzok S, Dehmel S, Sewald K, Brinkmann C, Curths C, Knauf S, Gruber J, Mätz-Rensing K, Dahlmann F, Braun A, Pöhlmann S (2017): Non-human primate orthologues of TMPRSS2 cleave and activate the influenza virus hemagglutinin. PLoS One. 12(5):e0176597. doi: 10.1371/journal.pone.0176597.
     
  7. Pöhlmann S, Suntz M, Akimkin V, Bleyer M, Kaul A (2017): Herpes B virus replication and viral lesions in the liver of a cynomolgus macaque which died from severe disease with rapid onset. Journal of Medical Primatology. 46(5):256-259. doi: 10.1111/jmp.12269.
     
  8. Gerlach T, Hensen L, Matrosovich T, Bergmann J, Winkler M, Peteranderl C, Klenk HD, Weber F, Herold S, Pöhlmann S, Matrosovich M (2017): pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs. Journal of Virology. 91(11). pii: e00246-17. doi: 10.1128/JVI.00246-17.
     
  9. Hoffmann M, Elzayat MT, Herbig E (2017): Hochpathogene Viren mittels Virus-Pseudotypen erforschen - Der Einfluss von hochreinem Wasser auf die Datenqualität. Laborpraxis.
     
  10. Brinkmann C, Hoffmann M, Lübke A, Nehlmeier I, Krämer-Kühl A, Winkler M, Pöhlmann S (2017): The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cells. PLoS One. 12(12):e0189073. doi: 10.1371/journal.pone.0189073.
     
  11. Guo Y, Nehlmeier I, Poole E, Sakonsinsiri C, Hondow N, Brown A, Li Q, Li S, Whitworth J, Li Z, Yu A, Brydson R, Turnbull WB, Pöhlmann S, Zhou D (2017): Dissecting Multivalent Lectin-Carbohydrate Recognition Using Polyvalent Multifunctional Glycan-Quantum Dots. Journal of the American Chemical Society. 139(34):11833-11844. doi: 10.1021/jacs.7b05104.

 

2016

  1. Kühn N, Bergmann S, Kasnitz N, Lambertz RLO, Keppner A, Pöhlmann S, Weiß S, Hummler E, Hatesuer B, Schughart K (2016): The proteolytic activation of A (H3N2) Influenza virus hemagglutinin is facilitated by different type II transmembrane serine proteases. Journal of Virology. 90(9):4298-307.

  2. Hoffmann M, González Hernández M, Berger E, Marzi A, Pöhlmann S (2016): The Glycoproteins of All Filovirus Species Use the Same Host Factors for Entry into Bat and Human Cells but Entry Efficiency Is Species Dependent. PLoS One. 11(2):e0149651.

  3. Guo Y, Sakonsinsiri C, Nehlmeier I, Fascione MA, Zhang H, Wang W, Pöhlmann S, Turnbull WB, Zhou D (2016): Compact, Polyvalent Mannose Quantum Dots as Sensitive, Ratiometric FRET Probes for Multivalent Protein-Ligand Interactions. Angew Chem Int Ed Engl. 55(15):4738-42.

  4. Hoffmann M, Krüger N, Zmora P, Wrensch F, Herrler G, Pöhlmann S (2016): The Hemagglutinin of Bat-Associated Influenza Viruses Is Activated by TMPRSS2 for pH-Dependent Entry into Bat but Not Human Cells. PLoS One. 11(3):e0152134.

  5. Spiegel M, Plegge T, Pöhlmann S (2016): The Role of Phlebovirus Glycoproteins in Viral Entry, Assembly and Release. Viruses. 8(7).

  6. Plegge T, Hofmann-Winkler H, Spiegel M, Pöhlmann S (2016): Evidence that Processing of the Severe Fever with Thrombocytopenia Syndrome Virus Gn/Gc Polyprotein Is Critical for Viral Infectivity and Requires an Internal Gc Signal Peptide. PLoS One. 11(11):e0166013.

  7. Brinkmann C, Nehlmeier I, Walendy-Gnirß K, Nehls J, González Hernández M, Hoffmann M, Qiu X, Takada A, Schindler M, Pöhlmann S (2016): The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies. J Virol. 90(24):11075-11086.

  8. Pöhlmann S, Schmitt C (2016): Orthommyxoviren: Influenza; Arenaviren. Springer Mikrobiologie Lehrbuch.

  9. Pöhlmann S, Spiegel M (2016): Bunyaviren. Springer Mikrobiologie Lehrbuch.

  10. Krüger N, Sauder C, Hoffmann M, Örvell C, Drexler JF, Rubin S, Herrler G (2016): Recombinant mumps viruses expressing the batMuV fusion glycoprotein are highly fusion active and neurovirulent. J Gen Virol. 97(11):2837-2848.

  11. Klippert A, Bleyer M, Sauermann U, Neumann B, Kaul A, Daskalaki M, Stolte-Leeb N, Kirchhoff F, Stahl-Hennig C (2016): Lymphocryptovirus-dependent occurrence of lymphoma in SIV-infected rhesus macaques with particular consideration to two uncommon cases of non-Hodgkin's lymphoma. Primate Biology.

2015

  1. Gierer S, Müller MA, Heurich A, Ritz D, Springstein B, Karsten CB, Schendzielorz A, Gnirß K, Drosten C, Pöhlmann S (2015): Inhibition of proprotein convertases abrogates processing of the middle eastern respiratory syndrome coronavirus spike protein in infected cells but does not reduce viral infectivity. Journal of Infectious Diseases. 211(6): 889-97.

  2. Hofmann-Winkler H, Gnirß K, Wrensch F, Pöhlmann S (2015): Comparative Analysis of Host Cell Entry of Ebola Virus From Sierra Leone, 2014, and Zaire, 1976. Journal of Infectious Diseases. 212(2): 172-80.

  3. Dahlmann F, Biedenkopf N, Babler A, Jahnen-Dechent W, Karsten CB, Gnirß K, Schneider H, Wrensch F, O'Callaghan CA, Bertram S, Herrler G, Becker S, Pöhlmann S, Hofmann-Winkler H (2015): Analysis of Ebola virus entry into macrophages. Journal of Infectious Diseases. 212(2): 247-57.

  4. Wrensch F, Karsten CB, Gnirß K, Hoffmann M, Lu K, Takada A, Winkler M, Simmons G, Pöhlmann S (2015): Interferon-Induced Transmembrane Protein–Mediated Inhibition of Host Cell Entry of Ebolaviruses. Journal of Infectious Diseases. 212(2): 210-8.

  5. Gnirß K, Zmora P, Blazejewska P, Winkler M, Lins A, Nehlmeier I, Gärtner S, Moldenhauer AS, Hofmann-Winkler H, Wolff T, Schindler M, Pöhlmann S (2015): Tetherin Sensitivity of Influenza A Viruses Is Strain Specific: Role of Hemagglutinin and Neuraminidase. Journal of Virology. 89(18): 9178-88.

  6. Karsten CB, Buettner FF, Cajic S, Nehlmeier I, Neumann B, Klippert A, Sauermann U, Reichl U, Gerardy-Schahn R, Rapp E, Stahl-Hennig C, Pöhlmann S (2015): Exclusive decoration of SIV Env with high-mannose type N-glycans is not compatible with mucosal transmission in rhesus macaques. Journal of Virology. 89(22): 11727-33.

  7. Zmora P, Moldenhauer AS, Hofmann-Winkler H, Pöhlmann S (2015): TMPRSS2 isoform 1 activates respiratory viruses and is expressed in viral target cells. PLoS One. 10(9): e0138380.

  8. Zmora P, Pöhlmann S (2015): New approaches to influenza therapy. Formatex Research Center. 5:1052-1059.

  9. Zhou Y, Vedantham P, Lu K, Agudelo J, Carrion R Jr, Nunneley JW, Barnard D, Pöhlmann S, McKerrow JH, Renslo AR, Simmons G (2015): Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Research. 116: 76-84.

2014

  1. van Breedam W, Pöhlmann S, Favoreel H W, Groot Raoul J de, Nauwynck H J (2014): Bitter-sweet symphony: glycan-lectin interactions in virus biology. FEMS Microbiology Reviews. 38(4): 598-632.

  2. Gehring G, Rohrmann K, Atenchong N, Mittler E, Becker S, Dahlmann F,  Pöhlmann S, Vondran F W R, David S, Manns M P, Ciesek S, Hahn T. von (2014): The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry. The Journal of Antimicrobial Chemotherapy. 69(8): 2123-31.

  3. Heurich A, Hofmann-Winkler H, Gierer S, Liepold T, Jahn O, Pöhlmann S (2014): TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike. Journal of Virology. 88(2): 1293-307.

  4. Koppensteiner H, Höhne K, Gondim M V, Gobert F-X, Widder M, Gundlach S, Heigele A, Kirchhoff F, Winkler M, Benaroch P, Schindler M (2014): Lentiviral Nef suppresses iron uptake in a strain specific manner through inhibition of Transferrin endocytosis. Retrovirology. 11:1.

  5. Gnirß K, Fiedler M, Krämer-Kühl A, Bolduan S, Mittler E, Becker S, Schindler M, Pöhlmann S (2014): Analysis of determinants in filovirus glycoproteins required for tetherin antagonism. Viruses. 6(4): 1654-71.

  6. Kiene M, Rethi B, Jansson M, Dillon S, Lee E, Lantto R, Wilson C, Pöhlmann S, Chiodi F (2014): Toll-like receptor 3 signalling up-regulates expression of the HIV co-receptor G-protein coupled receptor 15 on human CD4+ T cells. Plos One. 9(2): e88195.

  7. Eckert N, Wrensch F, Gärtner S, Palanisamy N, Goedecke U, Jäger N, Pöhlmann S, Winkler M (2014): Influenza A Virus Encoding Secreted Gaussia Luciferase as Useful Tool to Analyze Viral Replication and Its Inhibition by Antiviral Compounds and Cellular Proteins. Plos One. 9(5): e97695.

  8. Gierer S, Müller MA, Heurich A, Ritz D, Springstein B, Karsten CB, Schendzielorz A, Gnirß K, Drosten C, Pöhlmann S (2014): Inhibition of proprotein convertases abrogates processing of the MERS-coronavirus spike protein in infected cells but does not reduce viral infectivity. Journal of Infectious Diseases. 211(6): 889-97.

  9. Zmora P, Pöhlmann S (2014): Microscopy as a useful tool to study the proteolytic activation of influenza viruses. Microscopy: advances in scientific research and education. 6:725-731.

  10. Zmora P, Blazejewska P, Moldenhauer A.-S, Welsch K, Nehlmeier I, Wu Q, Schneider H, Pohlmann S, Bertram S (2014): DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry. Journal of Virology. 88(20): 12087-97.

  11. Wrensch F, Winkler M, Pöhlmann S (2014): IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms. Viruses. 6(9): 3683-98.

  12. Karsten CB, Pöhlmann S (2014): Attachment/Binding. Encyclopedia of AIDS (Springer).

2013

  1. Bertram S, Dijkman R, Habjan M, Heurich A, Gierer S, Glowacka I, Welsch K, Winkler M, Schneider H, Hofmann-Winkler H, Thiel V, Pöhlmann S (2013): TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium. Journal of Virology. 87(11): 6150-60.

  2. Gierer S, Bertram S, Kaup F, Wrensch F, Heurich A, Krämer-Kühl A, Welsch K, Winkler M, Meyer B, Drosten C, Dittmer U, Hahn T von, Simmons G, Hofmann H, Pöhlmann S (2013): The spike-protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2 and is targeted by neutralizing antibodies. Journal of Virology. 87(10): 5502-11.

  3. Hofmann H, Xingxing L, Zhang X, Liu W, Kühl A, Kaup F, Soldan S, González-Scarano F, Weber F, He Y, Pöhlmann S (2013): The severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as receptor for pH-dependent entry into human and animal cell lines. Journal of Virology. 87(8): 4384-94.

  4. Solomon Tsegaye T, Gnirß K, Rahe-Meyer N, Kiene M, Krämer-Kühl A, Behrens G, Münch J, Pöhlmann S (2013): Platelet activation suppresses HIV-1 infection of T cells. Retrovirology. 10-48.

  5. Simmons G, Pawel Z, Gierer S, Heurich A, Pöhlmann S (2013): Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research. Antiviral Research. 100(3): 605-14.

  6. Heurich A, Hofmann-Winkler H, Gierer S, Liepold T, Jahn O, Pöhlmann S (2013): TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the SARS-coronavirus spike-protein. Journal of Virology. 88(2): 1293-307.

  7. Gierer S, Hofmann-Winkler H, Albuali W H, Bertram S, Al-Rubaish, Abdullah A M, Yousef A A, Al-Nafaie A N, Al-Ali A K, Obeid O E, Alkharsah K R, Pöhlmann S (2013): Lack of MERS Coronavirus Neutralizing Antibodies in Humans, Eastern Province, Saudi Arabia. Emerging Infectious Diseases. 19(12): 2034-6.

  8. Bogdanow B, Weisbach H, Einem J von, Straschewski S, Voigt S, Winkler M, Hagemeier C, Wiebusch L (2013): Human cytomegalovirus tegument protein pp150 acts as a cyclin A2-CDK-dependent sensor of the host cell cycle and differentiation state. Proceedings of the National Academy of Sciences. 110(43): 17510-5.

  9. van Breedam W, Pöhlmann S, Favoreel H W, Groot R J de, Nauwynck H J (2013): Bitter-sweet symphony: glycan-lectin interactions in virus biology. FEMS Microbiology Reviews. 38(4): 598-632.

  10. Hatesuer B, Bertram S, Mehnert N, Bahgat M M, Nelson P S, Pöhlman S, Schughart K, Basler C F (2013): Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice. PLoS Pathogens. 9(12): e1003774.

  11. Lindemann D, Steffen I, Pöhlmann S (2013): Cellular entry of retroviruses. Viral entry into host cells. Springer. 128-149.

2012

  1. Bertram S, Heurich A, Lavender H, Gierer S, Danisch S, Perin P, Lucas Jared M, Nelson Peter S, Pöhlmann S, Soilleux Elizabeth J (2012): Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. PLoS One. 7(4): e35876.

  2. Gnirß K, Kühl A, Karsten C, Glowacka I, Bertram S, Kaup F, Hofmann H, Pöhlmann S (2012): Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression. Virology. 424(1): 3-10.

  3. Hofmann-Winkler H, Kaup F, Pöhlmann S (2012): Host Cell Factors in Filovirus Entry: Novel Players, New Insights. Viruses. 4(12): 3336-62.

  4. Kiene M, Marzi A, Urbanczyk A, Bertram S, Fisch T, Nehlmeier I, Gnirß K, Karsten C, Palesch D, Münch J, Chiodi F, Pöhlmann S, Steffen I (2012): The role of the alternative coreceptor GPR15 in SIV tropism for human cells. Virology. 433(1): 73-84.

  5. Kühl A, Pöhlmann S (2012): How Ebola Virus Counters the Interferon System. Zoonoses Public Health. 59(2): 116-31.

  6. Müller D, Schreiner S, Schmid M, Groitl P, Winkler M, Dobner T (2012): Functional Cooperation between Human Adenovirus Type 5 Early Region 4, Open Reading Frame 6 Protein, and Cellular Homeobox Protein HoxB7. J Virol. 86(15): 8296-308.

  7. Sinigalia E, Alvisi G, Segré CV, Mercorelli B, Muratore G, Winkler M, Hsiao HH, Urlaub H, Ripalti A, Chiocca S, Palù G, Loregian A, Sticht H (2012): The Human Cytomegalovirus DNA Polymerase Processivity Factor UL44 Is Modified by SUMO in a DNA-Dependent Manner. PLoS One. 7(11): e49630.

  8. Winkler M, Bertram S, Gnirß K, Nehlmeier I, Gawanbacht A, Kirchhoff F, Ehrhardt C, Ludwig S, Kiene M, Moldenhauer A, Goedecke U, Karsten C, Kühl A, Pöhlmann S (2012): Influenza A virus does not encode a tetherin antagonist with Vpu-like activity  and induces IFN-dependent tetherin expression in infected cells. PLoS One. 7(8): e43337.

2011

  1. Pipirou Z, Powlesland AS, Steffen I, Pöhlmann S, Taylor ME, Drickamer K (2011): Mouse LSECtin as a model for a human Ebola virus receptor. Glycobiology. 21(6): 806-12.

  2. Glowacka I, Bertram S, Müller MA, Allen P, Soilleux E, Pfefferle S, Steffen I, Tsegaye TS, He Y, Gnirss K, Niemeyer D, Schneider H, Drosten C, Pöhlmann S (2011): Evidence that TMPRSS2 activates the SARS-coronavirus spike-protein for membrane fusion and reduces viral control by the humoral immune response. J Virol. 85(9): 4122-34.

  3. Simmons G, Bertram S, Glowacka I, Steffen I, Chaipan C, Agudelo J, Lu K, Rennekamp AJ, Hofmann H, Bates P, Pöhlmann S (2011): Different host cell proteases activate the SARS-coronavirus spike-protein for cell-cell and virus-cell fusion. Virology. 413 (2): 265-74.

  4. Kühl A, Hoffmann M, Müller MA, Munster VJ, Gnirß K, Kiene M, Solomon T, Behrens G, Herrler G, Feldmann H, Drosten C, Pöhlmann S (2011): Comparative analysis 1 of Ebola virus glycoprotein interactions with human and bat cells. J. Infect. Dis. 204(3): 840-9.

  5. Kühl A, Banning C,  Marzi A, Votteler J, Steffen I, Bertram S, Glowacka I, Konrad A, Stürzl M, Guo JT, Schubert U, Feldmann H, Behrens G, Schindler M, Pöhlmann S (2011): The Ebola virus glycoprotein and HIV-1 Vpu employ 1 different strategies to counteract the antiviral factor tetherin. J. Infect. Dis. 204(3): 850-60.

  6. Hofmann H, Pöhlmann S (2011): DC-SIGN: Access Portal for Sweet Viral Killers. Cell Host Microbe. 10(1): 5-7.

  7. Pfefferle S, Schöpf J, Kögl M, Friedel CC, Müller MA, Carbajo-Lozoya J, Stellberger T, von Dall'armi E, Herzog P, Kallies S, Niemeyer D, Ditt V, Kuri T, Züst R, Pumpor K, Hilgenfeld R, Schwarz F, Zimmer R, Steffen I, Weber F, Thiel V, Herrler G, Thiel HJ, Schwegmann-Weßels C, Pöhlmann S, Haas J, Drosten C, von Brunn A (2011): The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors. PLoS Pathog. 7(10): e1002331.

  8. Bertram S, Glowacka I, Müller MA, Lavender H, Gnirss K, Nehlmeier I, He Y, Simmons G, Drosten C, Soilleux EJ, Jahn O, Steffen I, Pöhlmann S (2011): Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J Virol. 85(24): 13363-72.

2010

  1. Glowacka I, Bertram S, Herzog P, Pfefferle S, Steffen I, Weber F, Eichler J, Drosten C, Pöhlmann S (2010): Differential downregulation of ACE2 by the spike proteins of SARS-coronavirus and human coronavirus NL63. J. Virol. 84(2):1198-205.

  2. Steffen I, Pöhlmann S (2010): Peptide-based inhibitors of the HIV envelope protein and other class I viral fusion proteins. Curr. Pharm. Des. 16(9):1143-58.

  3. Kühl A, Münch J, Sauter D, Bertram S, Glowacka I, Steffen I, Specht A, Hofmann H, Schneider H, Behrens G, Pöhlmann S (2010): Calcium-modulating cyclophilin ligand does not restrict retrovirus release. Nat Med. 16(2): 155-6.

  4. Chaipan C, Steffen I, Solomon-Tsegaye T, Bertram S, Glowacka I, Kato Y, Schmökel J, Münch J, Gerardy-Schahn R, Pöhlmann S (2010): Incorporation of podoplanin into human immunodeficiency virus particles mediates binding to the attachment factor CLEC-2 and transmission to target cells. Retrovirology. 7:47.

  5. Bertram S, Glowacka I, Steffen I, Kühl A, Pöhlmann S (2010): Novel insights into proteolytic cleavage of influenza virus hemagglutinin. Rev. Med. Virol. 20(5): 298-310.

  6. Bertram S, Glowacka I, Blazejewska P, Soilleux E, Allen P, Danisch S, Steffen I, Choi SY, Park Y, Schneider H, Schughart K, Pöhlmann S (2010): TMPRSS2 facilitates trypsin-independent influenza virus spread in Caco-2 cells. J. Virol. 84(19): 10016-25.

  7. Zhou Y, Lu K, Pfefferle S, Bertram S, Glowacka I, Drosten C, Pöhlmann S, Simmons G (2010): A Single Asparagine-Linked Glycosylation Site of the SARS-Coronavirus Spike Glycoprotein Facilitates Inhibition by Mannose-Binding Lectin through Multiple Mechanisms. J. Virol. 84 (17): 8753-64.

  8. Solomon-Tsegaye T, Pöhlmann S (2010): The multiple facets of HIV attachment to dendritic cell lectins. Cell Microbiol. 12(11): 1553-61.